Nanotechnology is beginning to leave the laboratory and hit the high street – but health scares could stop this commercialisation process in its tracks.

The European Research Council’s plan to give grants to young researchers could help in the reform of Europe’s sclerotic research structures.

French and Belgian researchers have genetically modified strains of the bacteria as treatments for human gastrointestinal disorderse – and are keen to form licensing and partnering deals to take this research forward.

Philips has announced the first fruit of its deal with the venture capital firm New Venture Partners to spin out companies based on research carried out in Philips’ corporate research laboratories.

What is wrong with France’s basic research? There’s something missing, but it’s not resources, says Jean-Marc Schlenker.

Philippe Pouletty is a man with a mission - to make France synonymous with biotechnology. He has his work cut out...

There’s just one problem with the idea of a European Institute of Technology – some of the businesses and universities it’s supposed to benefit don’t want it.

Lost in the European patent maze? Or not sure where to start? Try finding your way around with the Science|Business guide to patents in Europe

JADO Technologies, a spin-out from the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, is developing small molecules that target cell membrane receptors, opening up a potential new avenue for drug delivery.

The buzz surrounding mobile TV is spurring cross-industry partnerships and attracting significant amounts of venture capital. But can 3G networks stand the pace?